Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

NAActive, not recruitingINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

October 10, 2024

Study Completion Date

January 31, 2030

Conditions
Bladder CancerProstate CancerKidney CancerPelvic TumorInterstitial CystitisCongenital AbnormalitiesEnd Stage Renal DiseaseRenal TumorKidney Injury
Interventions
DEVICE

RAS Prostatectomy

Subjects indicated for Robotic Assisted Surgery (RAS) for prostatectomy will have the RAS surgery using the Medtronic Hugo RAS system.

DEVICE

RAS Cystectomy

Subjects indicated for Robotic Assisted Surgery (RAS) for cystectomy will have the RAS surgery using the Medtronic Hugo RAS system.

DEVICE

RAS Nephrectomy

Subjects indicated for Robotic Assisted Surgery (RAS) for nephrectomy (Radical/Partial) will have the RAS surgery using the Medtronic Hugo RAS system.

Trial Locations (6)

10029

Mount Sinai, New York

27710

Duke Medical Center, Durham

44195

Cleveland Clinic, Cleveland

60612

University of Chiago, Chicago

91010

City of Hope, Duarte

98122

Swedish Medical Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic - MITG

INDUSTRY

NCT05696444 - Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) | Biotech Hunter | Biotech Hunter